Shilpa Medicare Limited (SHILPAMED.NS)
INR 826.7
(-0.45%)
INR 826.7
(-0.45%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.76 Billion INR | 2630.37% |
| 2022 | -53.99 Million INR | -104.48% |
| 2021 | 1.2 Billion INR | 1.38% |
| 2020 | 1.18 Billion INR | -31.07% |
| 2019 | 1.72 Billion INR | 52.82% |
| 2018 | 1.12 Billion INR | -1.96% |
| 2017 | 1.15 Billion INR | -17.59% |
| 2016 | 1.39 Billion INR | 9.1% |
| 2015 | 1.27 Billion INR | 21.27% |
| 2014 | 1.05 Billion INR | 5.34% |
| 2013 | 1 Billion INR | 85.84% |
| 2012 | 538.79 Million INR | 7.38% |
| 2011 | 501.76 Million INR | -12.33% |
| 2010 | 572.34 Million INR | -9.72% |
| 2009 | 634 Million INR | 179.98% |
| 2008 | 226.44 Million INR | 50.08% |
| 2007 | 150.88 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 464.91 Million INR | 7.04% |
| 2023 Q1 | 211.73 Million INR | 56.83% |
| 2023 Q4 | 434.33 Million INR | 7.55% |
| 2023 Q3 | 403.82 Million INR | 24.61% |
| 2023 Q2 | 324.08 Million INR | 53.06% |
| 2023 FY | 1.36 Billion INR | 2630.37% |
| 2022 Q3 | 102.73 Million INR | 215.17% |
| 2022 FY | -53.99 Million INR | -104.48% |
| 2022 Q1 | -18.5 Million INR | -103.88% |
| 2022 Q4 | 135.01 Million INR | 31.42% |
| 2022 Q2 | -89.2 Million INR | -382.03% |
| 2021 Q1 | 142.48 Million INR | 440.3% |
| 2021 FY | 1.2 Billion INR | 1.38% |
| 2021 Q4 | 477.4 Million INR | 95.35% |
| 2021 Q3 | 244.38 Million INR | -28.08% |
| 2021 Q2 | 339.8 Million INR | 138.48% |
| 2020 Q4 | 26.37 Million INR | -63.6% |
| 2020 FY | 1.18 Billion INR | -31.07% |
| 2020 Q2 | 1.54 Billion INR | 11.11% |
| 2020 Q3 | 72.45 Million INR | -95.3% |
| 2020 Q1 | 1.38 Billion INR | 303.62% |
| 2019 Q3 | 627.78 Million INR | -54.29% |
| 2019 FY | 1.72 Billion INR | 52.82% |
| 2019 Q1 | 927.57 Million INR | 155.23% |
| 2019 Q2 | 1.37 Billion INR | 48.06% |
| 2019 Q4 | 343.79 Million INR | -45.24% |
| 2018 Q3 | 709.96 Million INR | -20.29% |
| 2018 Q1 | 1.25 Billion INR | 8.19% |
| 2018 FY | 1.12 Billion INR | -1.96% |
| 2018 Q2 | 890.67 Million INR | -29.21% |
| 2018 Q4 | -1.67 Billion INR | -336.54% |
| 2017 FY | 1.15 Billion INR | -17.59% |
| 2017 Q2 | 1.34 Billion INR | 11.68% |
| 2017 Q1 | 1.2 Billion INR | -33.6% |
| 2017 Q4 | 1.16 Billion INR | 75.09% |
| 2017 Q3 | 664.23 Million INR | -50.68% |
| 2016 Q1 | 1.24 Billion INR | -5.4% |
| 2016 Q4 | 1.81 Billion INR | 47.72% |
| 2016 Q3 | 1.22 Billion INR | -3.86% |
| 2016 Q2 | 1.27 Billion INR | 2.94% |
| 2016 FY | 1.39 Billion INR | 9.1% |
| 2015 FY | 1.27 Billion INR | 21.27% |
| 2015 Q1 | 1.26 Billion INR | 311.99% |
| 2015 Q2 | 1.13 Billion INR | -9.77% |
| 2015 Q3 | 1.27 Billion INR | 11.79% |
| 2015 Q4 | 1.31 Billion INR | 3.2% |
| 2014 Q4 | 306.2 Million INR | 8.25% |
| 2014 FY | 1.05 Billion INR | 5.34% |
| 2014 Q1 | 899.35 Million INR | 143.98% |
| 2014 Q2 | 225.83 Million INR | -74.89% |
| 2014 Q3 | 282.86 Million INR | 25.25% |
| 2013 Q2 | 182 Million INR | 14.64% |
| 2013 FY | 1 Billion INR | 85.84% |
| 2013 Q4 | 368.62 Million INR | 26.29% |
| 2013 Q3 | 291.88 Million INR | 60.37% |
| 2013 Q1 | 158.75 Million INR | 13.44% |
| 2012 Q1 | 128.76 Million INR | -41.06% |
| 2012 Q3 | 127.21 Million INR | -19.25% |
| 2012 Q4 | 139.94 Million INR | 10.01% |
| 2012 Q2 | 157.52 Million INR | 22.34% |
| 2012 FY | 538.79 Million INR | 7.38% |
| 2011 Q2 | 99.65 Million INR | -24.66% |
| 2011 Q1 | 132.28 Million INR | 0.0% |
| 2011 FY | 501.76 Million INR | -12.33% |
| 2011 Q4 | 218.46 Million INR | 212.1% |
| 2011 Q3 | 69.99 Million INR | -29.76% |
| 2010 FY | 572.34 Million INR | -9.72% |
| 2009 FY | 634 Million INR | 179.98% |
| 2008 FY | 226.44 Million INR | 50.08% |
| 2007 FY | 150.88 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -155.213% |
| Ind-Swift Limited | 1.22 Billion INR | -206.826% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -659.138% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 96.401% |
| Innova Captab Limited | 2.53 Billion INR | -48.479% |
| Divi's Laboratories Limited | 18.31 Billion INR | 79.456% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 15.922% |
| Morepen Laboratories Limited | 4.17 Billion INR | 9.877% |
| Mankind Pharma Limited | 40.86 Billion INR | 90.796% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -120.335% |
| Laurus Labs Limited | 3.94 Billion INR | 4.737% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 3.316% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 58.108% |
| Alembic Limited | 767.77 Million INR | -389.935% |
| Hikal Limited | 1.49 Billion INR | -151.745% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 34.673% |
| Neuland Laboratories Limited | 5.31 Billion INR | 29.268% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 50.123% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 42.151% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 23.889% |
| Themis Medicare Limited | 1.3 Billion INR | -188.662% |
| RPG Life Sciences Limited | 2.29 Billion INR | -64.096% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 91.713% |
| Lupin Limited | 27.75 Billion INR | 86.449% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -505.702% |
| Wockhardt Limited | 140 Million INR | -2586.837% |
| Vaishali Pharma Limited | 6.29 Million INR | -59664.411% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -20.25% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -1657.415% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 27.509% |
| FDC Limited | 3.03 Billion INR | -23.991% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 94.446% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -1708.013% |
| Eris Lifesciences Limited | 5.18 Billion INR | 27.407% |
| Venus Remedies Limited | 534.65 Million INR | -603.557% |
| ZIM Laboratories Limited | 1.09 Billion INR | -242.549% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -205.57% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -581.952% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 47.939% |
| Albert David Limited | 1.33 Billion INR | -181.88% |
| Ajanta Pharma Limited | 19.67 Billion INR | 80.884% |
| Hester Biosciences Limited | 364.77 Million INR | -931.217% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 18.362% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 197.63% |
| Gufic Biosciences Limited | 2.89 Billion INR | -29.987% |
| Windlas Biotech Limited | 1.29 Billion INR | -189.599% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -35.017% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -132778.955% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -13599.366% |
| Granules India Limited | 6.52 Billion INR | 42.38% |
| Aarti Drugs Limited | 7.14 Billion INR | 47.381% |
| Bal Pharma Limited | 214.56 Million INR | -1653.083% |
| Alkem Laboratories Limited | 19.46 Billion INR | 80.672% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 96.394% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -97.32% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -1482.747% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -18110.554% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -59.316% |
| Medico Remedies Limited | 277.11 Million INR | -1257.39% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -87.233% |
| Ipca Laboratories Limited | 29.59 Billion INR | 87.29% |
| Brooks Laboratories Limited | -72.25 Million INR | 5306.184% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1409.15% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 85.153% |
| NATCO Pharma Limited | 25.96 Billion INR | 85.511% |
| Suven Life Sciences Limited | -1.22 Billion INR | 406.861% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 28.019% |
| Indoco Remedies Limited | 1.52 Billion INR | -146.758% |
| Alpa Laboratories Limited | 61.51 Million INR | -6014.886% |
| Lasa Supergenerics Limited | -458 Million INR | 921.295% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 191.41% |